CNBC August 4, 2019
Christina Farr

KEY POINTS
  • The market for infant formula is expected to reach $95 billion by 2026.
  • New companies are popping up in Silicon Valley to carve out a slice of the market.
  • These include Bobbie, which is developing a new formula based on European ingredients, and Sugarlogix, a biotech start-up that is looking to recreate the sugars found in human breast milk.

While working at Airbnb, Laura Modi noticed a strange trend among Bay Area mothers.

Many new parents were circumventing U.S. regulators by importing their formulas from Europe.

In Europe, there are different rules around the ingredients that brands are allowed to use in formulas, and some parents believe that European...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Digital Health, mHealth, Patient / Consumer, Precision Medicine, Primary care, Provider, Technology
Overturning Chevron Doctrine Could Impact Medicare’s Drug Selections For Price Negotiations
Merck Is Paying $588M for Potential Successor to Cancer Drug Juggernaut Keytruda
The financial burden of drug shortages: 7 study takeaways
What Stays True for U.S. Health Care Post #Election2024 (1) – Consumers’ Dissatisfaction with Drug Prices
Q&A: Generating data from neurons to teach AI the rules of the brain

Share This Article